MERISCREEN COVID-19 ANTIGEN TEST KIT

MeriScreen COVID-19 Antigen Detection Take a look at is a speedy immunochromatographic assay check for the qualitative detection of SARS-CoV-2 antigen in nasopharyngeal swab pattern from a human physique.

• COATED WITH HIGHLY PURIFIED MONOCLONAL ANTI-SARS-COV-2 ANTIBODY
• RESULTS IN 20 MINUTES
• SAMPLE IS NASOPHARYNGEAL SWAB
• SENSITIVITY: 96.6%
• SPECIFICITY: 100%

Precept

COVID-19 Antigen Detection Take a look at is an immunoassay check for speedy and qualitative detection of SARS-CoV-2 an infection from swab specimens. Monoclonal anti-SARS-CoV-2 antibodies are coated on the check line area. Antigens of SARS-CoV-2, if current within the specimens will work together with monoclonal antiSARS-CoV-2 antibodies conjugated with gold conjugate making antigen-antibodies conjugate advanced. This advanced migrates on the membrane by capillary motion, the place it will likely be captured by the monoclonal anti-SARS-CoV-2 antibody coated on the check line. A coloured check line could be seen within the consequence window if SARS-CoV-2 antigens are current within the specimen. The depth of coloured check line will fluctuate relying upon the quantity of SARS-CoV-2 antigen current within the specimen.

SKU:NCTCAG-01

AVAILABILITY:Offered Out

SHIPMENT:1 or 2 Working Days for Free

SIZE:25 Checks/Equipment

SENSITIVITY:96.6%

SPECIFICITY:100%

Please Be aware:

 Beneath listed kits are validated with the talked about batch quantity solely. Duty for batch to batch
consistency doesn’t lies with ICMR.
 Minimal acceptance standards of sensitivity and specificity of Fast Ag Take a look at Kits:
 Validated as a Level of Care Take a look at (POCT) with out transport to a laboratory setupSensitivity: 50% and above
Specificity: 95% and above
 Validated in a laboratory setup with samples collected in Viral Transport Medium (VTM)-
Sensitivity: 70% and above
Specificity: 99% and above
 Antigen primarily based speedy assessments that are US-FDA accredited can be utilized straight after due advertising approval from DCGI.

Transient methodology of use of COVID-19 Ag Respi-Strip (CorisBioConcept):
1. The Nasopharyngeal and/or Oropharyngeal swab will probably be collected from COVID-19 suspect affected person in Viral Transport Medium (VTM).
2. The collected swab in VTM will probably be delivered to the laboratory in acceptable chilly chain circumstances.
3. As soon as the pattern is dropped at the laboratory, it’ll have to be dealt with in a BSL-2 degree cupboard for aliquoting, placing in lysis buffer and loading the check strip.
 Steps 1 & 2 will probably be carried out as per the usual observe adopted for assortment and transport of samples for COVID-19 RT-PCR check.
 Step Three will have to be carried out as per producers’ directions given with the check equipment.

Straightforward to Use

Person-friendly interface; Requires no particular experience or in depth coaching.

Excessive Accuracy and Reliability

Glorious sensitivity and specifi­metropolis in comparison with molecular and viral tradition strategies.

Handy Storage Choices

Small instrument dimension and room-temp storage appropriate for any workplace or lab.

Lowered Person Errors

QR code scanning routinely identifi­es the check kind

Twin Testing Choices

Twin testing choices enable for higher testing flexibility

CA199 (Cancer antigen) ELISA test
13	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of CA199 (Cancer antigen)

CA153 (Cancer antigen) ELISA test
12	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of CA153 (Cancer antigen)

CA125 (Cancer antigen) ELISA test
11	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of CA125 (Cancer antigen)

NOVATest Antigen Rapid Test Kit (For Single Use) (NOVA Test)
nCov-500-01	Atlas Link Technology	1T	EUR 162

SARS-CoV-2 Rapid Antigen Test Nasal
9901-NCOV-03G	Roche Diagnostics	25 Tests/Kit	EUR 112.8
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

NOVATest Antigen Rapid Kit (NOVA Test)
nCov-500	Atlas Link Technology	20 Tests	EUR 162

PSA (Prostate-specific antigen) ELISA test
8	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of PSA (Prostate-specific antigen)

SARS-CoV-2 Antigen Rapid Test Kit
CoV2Ag-1	UnScience	1T	EUR 9.6
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again.

SARS-CoV-2 Antigen Rapid Test Kit
CoV2Ag-25	UnScience	25T/kit	EUR 42
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.

HBeAg hepatitis B E antigen ELISA test
79	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of HBeAg hepatitis B E antigen

HEV-Ag hepatitis E antigen ELISA test
94	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of HEV-Ag hepatitis E antigen

HBsAg hepatitis B surface antigen ELISA test
77	Biobase	96T/Box	Ask for price
Description: ELISA based test for quantitative detection of HBsAg hepatitis B surface antigen

Human Streptococcus Pneumoniae (SP) Antigen Rapid Test Kit
abx092096-20tests	Abbexa	20 tests	EUR 477.6

Recombinant human RHD antigen
P1958	FN Test	100ug	Ask for price
Description: Recombinant protein for human RHD antigen

Rat Cd44(CD44 antigen) ELISA Kit
ER0342	FN Test	96T	EUR 681.12
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 0.188 ng/ml

Avian Influenza Virus Antigen Rapid Test Kit (Colloidal gold)
abx092015-40tests	Abbexa	40 tests	EUR 518.4

Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva)
IOV87952	INVBIO	20T/kit	EUR 46.8
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications.

Rat CA125(Carbohydrate Antigen 125) ELISA Kit
ER0788	FN Test	96T	EUR 628.92
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 4.688U/ml

Mouse CA125(Carbohydrate Antigen 125) ELISA Kit
EM0887	FN Test	96T	EUR 628.92
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 1.875U/ml